Organism name | Catharanthus roseus (L.) G.DON |
---|---|
Genus | Catharanthus |
Family | Apocynaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Catharanthus roseus |
---|---|
Linked NCBI taxonomy ID | 4058 |
Linked level | species |
Family in NCBI taxonomy | Apocynaceae |
---|---|
ID | 4056 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001781
![]() |
Vinblastine
|
CHEMBL22969
CHEMBL159 CHEMBL150387 CHEMBL1315323 CHEMBL1437021 CHEMBL1518759 CHEMBL1625660 CHEMBL2311781 |
D014747
|
136 / 73 / 75 | 208 / 97 | No. 2360 | No. 4 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001781 | 1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001781 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00001781 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001781 | 7 / 37 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00001781 | 1 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001781 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00001781 | 1 / 1 |
O95342 | Bile salt export pump | drug | C00001781 | 2 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001781 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001781 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001781 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00001781 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001781 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001781 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001781 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001781 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001781 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001781 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001781 | 2 / 2 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001781 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001781 | 3 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001781 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001781 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001781 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001781 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001781 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001781 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 |
P04183 | Thymidine kinase, cytosolic | Enzyme | C00001781 | 0 / 1 |
P08183 | Multidrug resistance protein 1 | drug | C00001781 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001781 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001781 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001781 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001781 | 0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001781 | 1 / 8 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001781 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001781 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001781 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001781 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001781 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001781 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001781 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001781 | 1 / 1 |
P07437 | Tubulin beta chain | Structural | C00001781 | 0 / 0 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001781 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001781 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001781 | 1 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001781 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001781 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00001781 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00001781 | 0 / 0 |
P51151 | Ras-related protein Rab-9A | Unclassified protein | C00001781 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001781 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001781 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001781 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001781 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001781 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001781 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001781 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001781 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001781 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001781 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001781 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001781 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00001781 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001781 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001781 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00001781 | 1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001781 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001781 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001781 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001781 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001781 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001781 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001781 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001781 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001781 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001781 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001781 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001781 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001781 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001781 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001781 | 2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001781 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00001781 | 1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001781 | 0 / 0 |
P21439 | Multidrug resistance protein 3 | Enzyme | C00001781 | 3 / 2 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001781 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001781 | 1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001781 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001781 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001781 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001781 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001781 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001781 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001781 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001781 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001781 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001781 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001781 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001781 | 0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001781 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001781 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001781 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001781 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001781 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001781 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001781 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001781 | 1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001781 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001781 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001781 | 0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001781 | 1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001781 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00001781 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001781 | 1 / 2 |
Q13748 | Tubulin alpha-3C/D chain | Structural | C00001781 | 0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | C00001781 | 0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | C00001781 | 1 / 0 |
P04350 | Tubulin beta-4A chain | Structural | C00001781 | 2 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | C00001781 | 0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | C00001781 | 1 / 1 |
P68371 | Tubulin beta-4B chain | Structural | C00001781 | 0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | C00001781 | 2 / 1 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | C00001781 | 0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | C00001781 | 0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00001781 | 0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00001781 | 0 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | C00001781 | 0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | C00001781 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00001781
|
4363 | ABCC1, ABC29, ABCC, GS-X, MRP, MRP1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
C00001781
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00001781
|
3983 | ABLIM1, ABLIM, LIMAB1, LIMATIN, abLIM-1 | actin binding LIM protein 1 |
C00001781
|
39 | ACAT2 | acetyl-CoA acetyltransferase 2 (EC:2.3.1.9) |
C00001781
|
55856 | ACOT13, PNAS-27, THEM2 | acyl-CoA thioesterase 13 |
C00001781
|
52 | ACP1, HAAP | acid phosphatase 1, soluble (EC:3.1.3.2 3.1.3.48) |
C00001781
|
120 | ADD3, ADDL | adducin 3 (gamma) |
C00001781
|
316 | AOX1, AO, AOH1 | aldehyde oxidase 1 (EC:1.2.3.1) |
C00001781
|
27350 | APOBEC3C, A3C, APOBEC1L, ARDC2, ARDC4, ARP5, PBI, bK150C2.3 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C |
C00001781
|
521 | ATP5I, ATP5K | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E (EC:3.6.1.14) |
C00001781
|
9551 | ATP5J2, ATP5JL | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 (EC:3.6.1.14) |
C00001781
|
9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) |
C00001781
|
558 | AXL, JTK11, UFO | AXL receptor tyrosine kinase (EC:2.7.10.1) |
C00001781
|
329 | BIRC2, API1, HIAP2, Hiap-2, MIHB, RNF48, c-IAP1, cIAP1 | baculoviral IAP repeat containing 2 |
C00001781
|
330 | BIRC3, AIP1, API2, CIAP2, HAIP1, HIAP1, MALT2, MIHC, RNF49, c-IAP2 | baculoviral IAP repeat containing 3 |
C00001781
|
79444 | BIRC7, KIAP, LIVIN, ML-IAP, MLIAP, RNF50 | baculoviral IAP repeat containing 7 |
C00001781
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00001781
|
56951 | C5orf15, KCT2 | chromosome 5 open reading frame 15 |
C00001781
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001781
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001781
|
891 | CCNB1, CCNB | cyclin B1 |
C00001781
|
9133 | CCNB2, HsT17299 | cyclin B2 |
C00001781
|
959 | CD40LG, CD154, CD40L, HIGM1, IGM, IMD3, T-BAM, TNFSF5, TRAP, gp39, hCD40L | CD40 ligand |
C00001781
|
34411 |
C00001781
|
||
55143 | CDCA8, BOR, BOREALIN, DasraB, MESRGP | cell division cycle associated 8 |
C00001781
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00001781
|
1031 | CDKN2C, INK4C, p18, p18-INK4C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
C00001781
|
1058 | CENPA, CENP-A, CenH3 | centromere protein A |
C00001781
|
26586 | CKAP2, LB1, TMAP, se20-10 | cytoskeleton associated protein 2 |
C00001781
|
10063 | COX17 | COX17 cytochrome c oxidase copper chaperone |
C00001781
|
9377 | COX5A, COX, COX-VA, VA | cytochrome c oxidase subunit Va (EC:1.9.3.1) |
C00001781
|
1340 | COX6B1, COX6B, COXG, COXVIb1 | cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) (EC:1.9.3.1) |
C00001781
|
8804 | CREG1, CREG | cellular repressor of E1A-stimulated genes 1 |
C00001781
|
9419 | CRIPT | cysteine-rich PDZ-binding protein |
C00001781
|
1490 | CTGF, CCN2, HCS24, IGFBP8, NOV2 | connective tissue growth factor |
C00001781
|
6374 | CXCL5, ENA-78, SCYB5 | chemokine (C-X-C motif) ligand 5 |
C00001781
|
100528464 |
C00001781
|
||
28960 | DCPS, DCS1, HINT-5, HINT5, HSL1 | decapping enzyme, scavenger (EC:3.6.1.59) |
C00001781
|
9416 | DDX23, PRPF28, SNRNP100, U5-100K, U5-100KD, prp28 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 (EC:3.6.4.13) |
C00001781
|
51071 | DERA, DEOC | deoxyribose-phosphate aldolase (putative) (EC:4.1.2.4) |
C00001781
|
1677 | DFFB, CAD, CPAN, DFF-40, DFF2, DFF40 | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
C00001781
|
22943 | DKK1, DKK-1, SK | dickkopf WNT signaling pathway inhibitor 1 |
C00001781
|
27122 | DKK3, REIC, RIG | dickkopf WNT signaling pathway inhibitor 3 |
C00001781
|
29980 | DONSON, B17, C21orf60 | downstream neighbor of SON |
C00001781
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00001781
|
84455 | EFCAB7, RP4-534K7.1 | EF-hand calcium binding domain 7 |
C00001781
|
2013 | EMP2, XMP | epithelial membrane protein 2 |
C00001781
|
4072 | EPCAM, DIAR5, EGP-2, EGP314, EGP40, ESA, HNPCC8, KS1/4, KSA, M4S1, MIC18, MK-1, TACSTD1, TROP1 | epithelial cell adhesion molecule |
C00001781
|
2064 | ERBB2, CD340, HER-2, HER-2/neu, HER2, MLN_19, NEU, NGL, TKR1 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (EC:2.7.10.1) |
C00001781
|
2069 | EREG, ER | epiregulin |
C00001781
|
2109 | ETFB, MADD | electron-transfer-flavoprotein, beta polypeptide |
C00001781
|
5393 | EXOSC9, PM/Scl-75, PMSCL1, RRP45, Rrp45p, p5, p6 | exosome component 9 (EC:3.1.13.-) |
C00001781
|
10447 | FAM3C, ILEI | family with sequence similarity 3, member C |
C00001781
|
388650 | FAM69A | family with sequence similarity 69, member A |
C00001781
|
55120 | FANCL, FAAP43, PHF9, POG | Fanconi anemia, complementation group L |
C00001781
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00001781
|
2237 | FEN1, FEN-1, MF1, RAD2 | flap structure-specific endonuclease 1 |
C00001781
|
2280 | FKBP1A, FKBP-12, FKBP-1A, FKBP1, FKBP12, PKC12, PKCI2, PPIASE | FK506 binding protein 1A, 12kDa (EC:5.2.1.8) |
C00001781
|
2313 | FLI1, EWSR2, SIC-1 | Fli-1 proto-oncogene, ETS transcription factor |
C00001781
|
2335 | FN1, CIG, ED-B, FINC, FN, FNZ, GFND, GFND2, LETS, MSF | fibronectin 1 |
C00001781
|
8061 | FOSL1, FRA, FRA1, fra-1 | FOS-like antigen 1 |
C00001781
|
50486 | G0S2, RP1-28O10.2 | G0/G1switch 2 |
C00001781
|
79017 | GGCT, C7orf24, CRF21, GCTG, GGC | gamma-glutamylcyclotransferase (EC:2.3.2.4) |
C00001781
|
2677 | GGCX, VKCFD1 | gamma-glutamyl carboxylase (EC:4.1.1.90) |
C00001781
|
51053 | GMNN, Gem | geminin, DNA replication inhibitor |
C00001781
|
79158 | GNPTAB, GNPTA, ICD | N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (EC:2.7.8.17) |
C00001781
|
11245 | GPR176, HB-954 | G protein-coupled receptor 176 |
C00001781
|
29899 | GPSM2, CMCS, DFNB82, LGN, PINS | G-protein signaling modulator 2 |
C00001781
|
2969 | GTF2I, BAP135, BTKAP1, DIWS, GTFII-I, IB291, SPIN, TFII-I, WBS, WBSCR6 | general transcription factor IIi |
C00001781
|
2971 | GTF3A, AP2, TFIIIA | general transcription factor IIIA |
C00001781
|
51512 | GTSE1, B99 | G-2 and S-phase expressed 1 |
C00001781
|
2990 | GUSB, BG, MPS7 | glucuronidase, beta (EC:3.2.1.31) |
C00001781
|
3033 | HADH, HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD | hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) |
C00001781
|
3059 | HCLS1, CTTNL, HS1 | hematopoietic cell-specific Lyn substrate 1 |
C00001781
|
3006 | HIST1H1C, H1.2, H1C, H1F2, H1s-1 | histone cluster 1, H1c |
C00001781
|
3146 | HMGB1, HMG1, HMG3, SBP-1 | high mobility group box 1 |
C00001781
|
3148 | HMGB2, HMG2 | high mobility group box 2 |
C00001781
|
9324 | HMGN3, PNAS-25, TRIP7 | high mobility group nucleosomal binding domain 3 |
C00001781
|
3161 | HMMR, CD168, IHABP, RHAMM | hyaluronan-mediated motility receptor (RHAMM) |
C00001781
|
9456 | HOMER1, HOMER, HOMER1A, HOMER1B, HOMER1C, SYN47, Ves-1 | homer homolog 1 (Drosophila) |
C00001781
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001781
|
3398 | ID2, GIG8, ID2A, ID2H, bHLHb26 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
C00001781
|
3418 | IDH2, D2HGA2, ICD-M, IDH, IDHM, IDP, IDPM, mNADP-IDH | isocitrate dehydrogenase 2 (NADP+), mitochondrial (EC:1.1.1.42) |
C00001781
|
10643 | IGF2BP3, CT98, IMP-3, IMP3, KOC1, VICKZ3 | insulin-like growth factor 2 mRNA binding protein 3 |
C00001781
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00001781
|
3598 | IL13RA2, CD213A2, CT19, IL-13R, IL13BP | interleukin 13 receptor, alpha 2 |
C00001781
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001781
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001781
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001781
|
3624 | INHBA, EDF, FRP | inhibin, beta A |
C00001781
|
3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00001781
|
9270 | ITGB1BP1, ICAP-1A, ICAP-1B, ICAP-1alpha, ICAP1, ICAP1A, ICAP1B | integrin beta 1 binding protein 1 |
C00001781
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001781
|
23189 | KANK1, ANKRD15, CPSQ2, KANK | KN motif and ankyrin repeat domains 1 |
C00001781
|
23254 | KAZN, KAZ | kazrin, periplakin interacting protein |
C00001781
|
57698 | KIAA1598 |
C00001781
|
|
3832 | KIF11, EG5, HKSP, KNSL1, MCLMR, TRIP5 | kinesin family member 11 |
C00001781
|
56992 | KIF15, HKLP2, KNSL7, NY-BR-62 | kinesin family member 15 |
C00001781
|
23095 | KIF1B, CMT2, CMT2A, CMT2A1, HMSNII, KLP, NBLST1 | kinesin family member 1B |
C00001781
|
10112 | KIF20A, MKLP2, RAB6KIFL | kinesin family member 20A |
C00001781
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00001781
|
24137 | KIF4A, KIF4, KIF4G1 | kinesin family member 4A |
C00001781
|
3838 | KPNA2, IPOA1, QIP2, RCH1, SRP1alpha | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
C00001781
|
4001 | LMNB1, ADLD, LMN, LMN2, LMNB | lamin B1 |
C00001781
|
1902 | LPAR1, EDG2, GPR26, Gpcr26, LPA1, Mrec1.3, VZG1, edg-2, rec.1.3, vzg-1 | lysophosphatidic acid receptor 1 |
C00001781
|
55227 | LRRC1, LANO, dJ523E19.1 | leucine rich repeat containing 1 |
C00001781
|
51690 | LSM7, YNL147W | LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) |
C00001781
|
4053 | LTBP2, C14orf141, GLC3D, LTBP3, MSPKA, MSTP031, WMS3 | latent transforming growth factor beta binding protein 2 |
C00001781
|
4085 | MAD2L1, HSMAD2, MAD2 | MAD2 mitotic arrest deficient-like 1 (yeast) |
C00001781
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00001781
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00001781
|
8550 | MAPKAPK5, MAPKAP-K5, MK-5, MK5, PRAK | mitogen-activated protein kinase-activated protein kinase 5 (EC:2.7.11.1) |
C00001781
|
9833 | MELK, HPK38 | maternal embryonic leucine zipper kinase (EC:2.7.11.1 2.7.10.2) |
C00001781
|
4311 | MME, CALLA, CD10, NEP, SFE | membrane metallo-endopeptidase (EC:3.4.24.11) |
C00001781
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00001781
|
5891 | MOK, RAGE, RAGE-1, RAGE1 | MOK protein kinase (EC:2.7.11.22) |
C00001781
|
78988 | MRP63, bMRP63 | mitochondrial ribosomal protein 63 |
C00001781
|
51765 | MST4, MASK | serine/threonine protein kinase MST4 (EC:2.7.11.1) |
C00001781
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001781
|
26292 | MYCBP, AMY-1 | MYC binding protein |
C00001781
|
64151 | NCAPG, CAPG, CHCG, NY-MEL-3 | non-SMC condensin I complex, subunit G |
C00001781
|
23397 | NCAPH, BRRN1, CAP-H | non-SMC condensin I complex, subunit H |
C00001781
|
10403 | NDC80, HEC, HEC1, HsHec1, KNTC2, TID3, hsNDC80 | NDC80 kinetochore complex component |
C00001781
|
4694 | NDUFA1, CI-MWFE, MWFE, ZNF183 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa (EC:1.6.99.3) |
C00001781
|
51079 | NDUFA13, B16.6, CDA016, GRIM-19, GRIM19 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
C00001781
|
4696 | NDUFA3, B9, CI-B9 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa |
C00001781
|
4701 | NDUFA7, B14.5a | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
C00001781
|
4708 | NDUFB2, AGGG, CI-AGGG | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3) |
C00001781
|
4717 | NDUFC1, KFYI | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
C00001781
|
4718 | NDUFC2, B14.5b, CI-B14.5b, HLC-1, NADHDH2 | NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa |
C00001781
|
4726 | NDUFS6, CI-13kA, CI-13kD-A, CI13KDA | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) |
C00001781
|
4729 | NDUFV2, CI-24k | NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa (EC:1.6.5.3 1.6.99.3) |
C00001781
|
4776 | NFATC4, NF-ATc4, NFAT3 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
C00001781
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00001781
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00001781
|
8439 | NSMAF, FAN | neutral sphingomyelinase (N-SMase) activation associated factor |
C00001781
|
55270 | NUDT15, MTH2, RP11-90M2.1 | nudix (nucleoside diphosphate linked moiety X)-type motif 15 (EC:3.6.1.55) |
C00001781
|
11163 | NUDT4, DIPP2, DIPP2alpha, DIPP2beta | nudix (nucleoside diphosphate linked moiety X)-type motif 4 (EC:3.6.1.52) |
C00001781
|
51203 | NUSAP1, ANKT, BM037, LNP, NUSAP, PRO0310p1, Q0310, SAPL | nucleolar and spindle associated protein 1 |
C00001781
|
4946 | OAZ1, AZI, OAZ | ornithine decarboxylase antizyme 1 |
C00001781
|
11339 | OIP5, 5730547N13Rik, CT86, LINT-25, MIS18B, MIS18beta, hMIS18beta | Opa interacting protein 5 |
C00001781
|
401903 |
C00001781
|
||
126370 | OR1I1, OR19-20, OR1I1P, OR1I1Q | olfactory receptor, family 1, subfamily I, member 1 |
C00001781
|
23594 | ORC6, ORC6L | origin recognition complex, subunit 6 |
C00001781
|
114884 | OSBPL10, ORP10, OSBP9 | oxysterol binding protein-like 10 |
C00001781
|
3355109 |
C00001781
|
||
5162 | PDHB, PDHBD, PDHE1-B, PHE1B | pyruvate dehydrogenase (lipoamide) beta (EC:1.2.4.1) |
C00001781
|
53918 | PELO, PRO1770 | pelota homolog (Drosophila) |
C00001781
|
10857 | PGRMC1, HPR6.6, MPR | progesterone receptor membrane component 1 |
C00001781
|
8544 | PIR | pirin (iron-binding nuclear protein) (EC:1.13.11.24) |
C00001781
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00001781
|
9055 | PRC1, ASE1 | protein regulator of cytokinesis 1 |
C00001781
|
5689 | PSMB1, HC5, PMSB1, PSC5 | proteasome (prosome, macropain) subunit, beta type, 1 (EC:3.4.25.1) |
C00001781
|
23198 | PSME4, PA200 | proteasome (prosome, macropain) activator subunit 4 |
C00001781
|
10728 | PTGES3, P23, TEBP, cPGES | prostaglandin E synthase 3 (cytosolic) (EC:5.3.99.3) |
C00001781
|
9232 | PTTG1, EAP1, HPTTG, PTTG, TUTR1 | pituitary tumor-transforming 1 |
C00001781
|
5806 | PTX3, TNFAIP5, TSG-14 | pentraxin 3, long |
C00001781
|
54870 | QRICH1 | glutamine-rich 1 |
C00001781
|
80223 | RAB11FIP1, NOEL1A, RCP, rab11-FIP1 | RAB11 family interacting protein 1 (class I) |
C00001781
|
29127 | RACGAP1, CYK4, HsCYK-4, ID-GAP, MgcRacGAP | Rac GTPase activating protein 1 |
C00001781
|
5902 | RANBP1, HTF9A | RAN binding protein 1 |
C00001781
|
5980 | REV3L, POLZ, REV3 | REV3-like, polymerase (DNA directed), zeta, catalytic subunit (EC:2.7.7.7) |
C00001781
|
5985 | RFC5, RFC36 | replication factor C (activator 1) 5, 36.5kDa |
C00001781
|
6119 | RPA3, REPA3 | replication protein A3, 14kDa |
C00001781
|
393715 |
C00001781
|
||
6241 | RRM2, R2, RR2, RR2M | ribonucleotide reductase M2 (EC:1.17.4.1) |
C00001781
|
5055 | SERPINB2, HsT1201, PAI, PAI-2, PAI2, PLANH2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
C00001781
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00001781
|
94081 | SFXN1 | sideroflexin 1 |
C00001781
|
6502 | SKP2, FBL1, FBXL1, FLB1, p45 | S-phase kinase-associated protein 2, E3 ubiquitin protein ligase |
C00001781
|
6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00001781
|
79622 | SNRNP25, C16orf33 | small nuclear ribonucleoprotein 25kDa (U11/U12) |
C00001781
|
29887 | SNX10, OPTB8 | sorting nexin 10 |
C00001781
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001781
|
6272 | SORT1, Gp95, LDLCQ6, NT3 | sortilin 1 |
C00001781
|
6715 | SRD5A1, S5AR_1 | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) (EC:1.3.1.22) |
C00001781
|
5552 | SRGN, PPG, PRG, PRG1 | serglycin |
C00001781
|
8614 | STC2, STC-2, STCRP | stanniocalcin 2 |
C00001781
|
6801 | STRN, SG2NA | striatin, calmodulin binding protein |
C00001781
|
8803 | SUCLA2, A-BETA, MTDPS5, SCS-betaA | succinate-CoA ligase, ADP-forming, beta subunit (EC:6.2.1.5) |
C00001781
|
8802 | SUCLG1, GALPHA, MTDPS9, SUCLA1 | succinate-CoA ligase, alpha subunit (EC:6.2.1.4 6.2.1.5) |
C00001781
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001781
|
85360 | SYDE1, 7h3 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
C00001781
|
9882 | TBC1D4, AS160 | TBC1 domain family, member 4 |
C00001781
|
6996 | TDG, hTDG | thymine-DNA glycosylase (EC:3.2.2.29) |
C00001781
|
7980 | TFPI2, PP5, REF1, TFPI-2 | tissue factor pathway inhibitor 2 |
C00001781
|
80194 | TMEM134 | transmembrane protein 134 |
C00001781
|
28978 | TMEM14A, C6orf73 | transmembrane protein 14A |
C00001781
|
80008 | TMEM156 | transmembrane protein 156 |
C00001781
|
27346 | TMEM97, MAC30 | transmembrane protein 97 |
C00001781
|
7112 | TMPO, CMD1T, LAP2, LEMD4, PRO0868, TP | thymopoietin |
C00001781
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00001781
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001781
|
7164 | TPD52L1, D53, hD53 | tumor protein D52-like 1 |
C00001781
|
23321 | TRIM2, CMT2R, RNF86 | tripartite motif containing 2 |
C00001781
|
57570 | TRMT5, KIAA1393, TRM5 | tRNA methyltransferase 5 (EC:2.1.1.228) |
C00001781
|
27075 | TSPAN13, NET-6, NET6, TM4SF13 | tetraspanin 13 |
C00001781
|
8458 | TTF2, HuF2 | transcription termination factor, RNA polymerase II |
C00001781
|
7272 | TTK, CT96, ESK, MPH1, MPS1, MPS1L1, PYT | TTK protein kinase (EC:2.7.12.1) |
C00001781
|
659925 |
C00001781
|
||
7424 | VEGFC, Flt4-L, VRP | vascular endothelial growth factor C |
C00001781
|
80349 | WDR61, REC14, SKI8 | WD repeat domain 61 |
C00001781
|
55884 | WSB2, SBA2 | WD repeat and SOCS box containing 2 |
C00001781
|
10971 | YWHAQ, 14-3-3, 1C5, HS1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
C00001781
|
79844 | ZDHHC11, ZNF399 | zinc finger, DHHC-type containing 11 (EC:2.3.1.225) |
C00001781
|
678 | ZFP36L2, BRF2, ERF-2, ERF2, RNF162C, TIS11D | ZFP36 ring finger protein-like 2 |
C00001781
|
11130 | ZWINT, HZwint-1, KNTC2AP, ZWINT1 | ZW10 interacting kinetochore protein |
C00001781
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#605479 | Cholestasis, benign recurrent intrahepatic, 2; bric2 |
O95342
|
#614972 | Cholestasis, intrahepatic, of pregnancy 3; icp3 |
P21439
|
#601847 | Cholestasis, progressive familial intrahepatic, 2; pfic2 |
O95342
|
#602347 | Cholestasis, progressive familial intrahepatic, 3; pfic3 |
P21439
|
#114500 | Colorectal cancer; crc |
P84022
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#600803 | Gallbladder disease 1; gbd1 |
P21439
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#607276 | Resting heart rate, variation in |
P08588
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00624 | Familial cholestasis |
O95342
(related)
P21439 (related) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04183
(marker)
P04637 (related) |
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01213 | Gallbladder disease |
P21439
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D015746 | Abdominal Pain |
C00001781
|
C538231 | Adenocarcinoma of lung |
C00001781
|
D000380 | Agranulocytosis |
C00001781
|
D000505 | Alopecia |
C00001781
|
D000787 | Angina Pectoris |
C00001781
|
D018771 | Arthralgia |
C00001781
|
D001342 | Autonomic Nervous System Diseases |
C00001781
|
D019575 | Blindness, Cortical |
C00001781
|
C536572 | Bone Marrow failure syndromes |
C00001781
|
D001919 | Bradycardia |
C00001781
|
D001943 | Breast Neoplasms |
C00001781
|
D006502 | Budd-Chiari Syndrome |
C00001781
|
D002277 | Carcinoma |
C00001781
|
D018236 | Carcinoma, Embryonal |
C00001781
|
D002289 | Carcinoma, Non-Small-Cell Lung |
C00001781
|
D002292 | Carcinoma, Renal Cell |
C00001781
|
D002295 | Carcinoma, Transitional Cell |
C00001781
|
D002637 | Chest Pain |
C00001781
|
D023341 | Chills |
C00001781
|
D015179 | Colorectal Neoplasms |
C00001781
|
D003248 | Constipation |
C00001781
|
D003324 | Coronary Artery Disease |
C00001781
|
D003967 | Diarrhea |
C00001781
|
D004342 | Drug Hypersensitivity |
C00001781
|
D062787 | Drug Overdose |
C00001781
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001781
|
D004407 | Dysgerminoma |
C00001781
|
D007172 | Erectile Dysfunction |
C00001781
|
D005157 | Facial Pain |
C00001781
|
D005334 | Fever |
C00001781
|
D005734 | Gangrene |
C00001781
|
D006258 | Head and Neck Neoplasms |
C00001781
|
D006314 | Hearing Loss, Conductive |
C00001781
|
D006333 | Heart Failure |
C00001781
|
D006463 | Hemolytic-Uremic Syndrome |
C00001781
|
D006504 | Hepatic Veno-Occlusive Disease |
C00001781
|
D006505 | Hepatitis |
C00001781
|
D006646 | Histiocytosis, Langerhans-Cell |
C00001781
|
D006689 | Hodgkin Disease |
C00001781
|
D006932 | Hyperbilirubinemia |
C00001781
|
D006973 | Hypertension |
C00001781
|
D006978 | Hypertension, Renovascular |
C00001781
|
D006987 | Hypesthesia |
C00001781
|
D007008 | Hypokalemia |
C00001781
|
D007010 | Hyponatremia |
C00001781
|
D007022 | Hypotension |
C00001781
|
D045823 | Ileus |
C00001781
|
D007177 | Inappropriate ADH Syndrome |
C00001781
|
D007511 | Ischemia |
C00001781
|
D007674 | Kidney Diseases |
C00001781
|
D007970 | Leukopenia |
C00001781
|
D008113 | Liver Neoplasms |
C00001781
|
D008545 | Melanoma |
C00001781
|
D008881 | Migraine Disorders |
C00001781
|
D009120 | Muscle Cramp |
C00001781
|
D018908 | Muscle Weakness |
C00001781
|
D009135 | Muscular Diseases |
C00001781
|
D009188 | Myelitis, Transverse |
C00001781
|
D009203 | Myocardial Infarction |
C00001781
|
D017202 | Myocardial Ischemia |
C00001781
|
D009325 | Nausea |
C00001781
|
D009362 | Neoplasm Metastasis |
C00001781
|
D009374 | Neoplasms, Experimental |
C00001781
|
D009373 | Neoplasms, Germ Cell and Embryonal |
C00001781
|
D009443 | Neuritis |
C00001781
|
D020258 | Neurotoxicity Syndromes |
C00001781
|
D009503 | Neutropenia |
C00001781
|
D010051 | Ovarian Neoplasms |
C00001781
|
D010146 | Pain |
C00001781
|
D010291 | Paresis |
C00001781
|
D010292 | Paresthesia |
C00001781
|
D016506 | Pemphigus, Benign Familial |
C00001781
|
D010523 | Peripheral Nervous System Diseases |
C00001781
|
D010538 | Peritonitis |
C00001781
|
D011014 | Pneumonia |
C00001781
|
D054038 | Posterior Leukoencephalopathy Syndrome |
C00001781
|
D011471 | Prostatic Neoplasms |
C00001781
|
D011507 | Proteinuria |
C00001781
|
D011552 | Pseudomonas Infections |
C00001781
|
D011658 | Pulmonary Fibrosis |
C00001781
|
D011928 | Raynaud Disease |
C00001781
|
D012021 | Reflex, Abnormal |
C00001781
|
D012078 | Renal Artery Obstruction |
C00001781
|
D051437 | Renal Insufficiency |
C00001781
|
D012208 | Rhabdomyosarcoma |
C00001781
|
D012514 | Sarcoma, Kaposi |
C00001781
|
D012640 | Seizures |
C00001781
|
D018805 | Sepsis |
C00001781
|
D018243 | Teratocarcinoma |
C00001781
|
D013736 | Testicular Neoplasms |
C00001781
|
D013921 | Thrombocytopenia |
C00001781
|
D013927 | Thrombosis |
C00001781
|
D014523 | Urethral Neoplasms |
C00001781
|
D001749 | Urinary Bladder Neoplasms |
C00001781
|
D014625 | Vaginal Neoplasms |
C00001781
|
D014652 | Vascular Diseases |
C00001781
|
D014839 | Vomiting |
C00001781
|